Released Mar 30, 2015, after the close
10-Q filed Mar 31, 2015, 182 days after period end · 0001193125-15-112321
Q3 2014 · 10-Q
Revenue$100.99M$100.99M +10.0% vs Q3 2013+0.0% vs Q2 2014
Net Income$452.00K$452.00K N/M vs Q3 2013N/M vs Q2 2014
EPS Diluted$0.02$0.02 N/M vs Q3 2013N/M vs Q2 2014
Gross Profit$75,726,000+13.5%
Operating Income$6,508,000N/M
Operating Cash Flowderived$18,092,000+1.8%
Free Cash Flowderived$12,906,000+15.6%
Margins · derived
Gross margin75.0%+2.3 pt vs Q3 2013
Operating margin6.4%+21.8 pt vs Q3 2013
Net margin0.4%+21.0 pt vs Q3 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $100.99M | $91.81M | $105.82M | $111.51M |
| Net Income | $452.00K | -$18.84M | $3.75M | $10.08M |
| EPS Diluted | $0.02 | -$1.04 | $0.19 | $0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR